HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 07, July 2019 – Traditional Chinese medicine in modern healthcare — Integrating both worlds       » China approves norovirus vaccine for clinical trial       » AI offers breakthrough in cancer diagnosis       » Digital mental health strategy in China       » A wearable that's not to be laughed at       » Junk food could be responsible for the food allergy epidemic      
INSIDE INDUSTRY
Bayer, NUS Enterprise partner to start Healthy Hearts, Healthy Aging initiative
Initiative to drive the adoption of health innovation which enables long-term prevention of stroke, heart attacks and other serious cardiovascular events

By 2050, one in four people in Asia and the Pacific will be over 60 years old. An increase in age is inevitably accompanied by a concurrent increase in chronic medical conditions like cardiovascular diseases (CVDs).

As the cause of more than 17 million deaths annually, with Asia accounting for about half of them, CVD is the world鈥檚 largest noncommunicable disease (NCD) by morbidity and mortality. This burden is projected to rise with the region鈥檚 ageing population.

Bayer in partnership with NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS) announced a new initiative to drive adoption of health innovation in CVD prevention in seniors in the Asia-Pacific region.

The initiative - Healthy Hearts, Healthy Aging, comprises of a forum, report, among other initiatives, aims to bring healthcare experts, policy makers, innovators, academia, non-governmental organizations (NGOs) and corporations together to examine the role of health innovations in preventing serious cardiovascular (CV) events such as strokes and heart attacks in seniors living with CVD.

Bayer will draw on NUS Enterprise鈥檚 expertise and experience in engaging the regional startup ecosystem for innovation to develop a report which gathers research data and critical insights from multi-disciplinary teams of experts across the region.

The report will examine the CV health imperatives associated with ageing populations across the Asia-Pacific.

The report will also gather recommendations on how different stakeholders can collaborate to enhance the adoption of health innovation in the long-term preventive care of CVD patients. It is planned for a June 2019 completion.

Click here for the complete issue.

NEWS CRUNCH  
news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy